Angel Garcia-Alonso

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Gary Middleton, Paul Silcocks, Trevor F. Cox et al. · The Lancet Oncology · 2014 · 374 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

Susan Dutton, David Ferry, Jane Blazeby et al. · The Lancet Oncology · 2014 · 330 citations · Full text

Medicine, Oncology, Pharmacology +6

Prospective Study of Pregnancy in Systemic Lupus Erythematosus. Results of a Multidisciplinary Approach

Gregorio Mintz, José Niz, G Varela Gutierrez et al. · Obstetrical & Gynecological Survey · 1987 · 240 citations

Medicine, Obstetrics, Maternal-fetal Medicine +2

Gefitinib and <i>EGFR</i> Gene Copy Number Aberrations in Esophageal Cancer

Russell Petty, Åsa Dahle-Smith, David A. Stevenson et al. · Journal of Clinical Oncology · 2017 · 140 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Prospective Study of Pregnancy in Systemic Lupus Erythematosus. Results of a Multidisciplinary Approach

Gregorio Mintz, José Niz, G Varela Gutierrez et al. · Obstetrical & Gynecological Survey · 1987 · 136 citations

Medicine, Obstetrics, Maternal-fetal Medicine +2